Cargando…
788. Therapeutic Drug Monitoring for Pyrazinamide During Tuberculosis Treatment: What Is the Diagnostic Accuracy?
BACKGROUND: Pyrazinamide (PZA) is a key drug for both drug-sensitive and drug-resistant tuberculosis (TB). Patients co-infected with TB and human immunodeficiency virus (HIV) are more likely to have low blood levels of PZA, associated with inferior outcomes. Therapeutic drug monitoring (TDM) with sp...
Autores principales: | Anderson, Ginger, Vinnard, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254894/ http://dx.doi.org/10.1093/ofid/ofy210.795 |
Ejemplares similares
-
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment
por: Anderson, Ginger, et al.
Publicado: (2022) -
Posters P788 - P999
Publicado: (2005) -
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
por: Vinnard, Christopher, et al.
Publicado: (2017) -
788 INCREASE IN ALCOHOLIC HEPATITIS CASES DURING COVID PANDEMIC IN THE US
por: Nair, Geethu G., et al.
Publicado: (2021) -
Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid
por: Zeng, Haifeng, et al.
Publicado: (2013)